Patients using diabetes medications should be aware of hypoglycemia risk when combining therapies, particularly if insulin or sulfonylureas are involved
1 With patent challenges to branded GLP-1 products advancing across multiple jurisdictions and demand for affordable obesity and diabetes therapies continuing to grow, the generic entry raises practical questions for the broader GLP-1 commercial ecosystem: how It is estimated 589 million adults are currently living with diabetes worldwide a number projected to reach 853 million by 2050 underscoring the scale of the patient population these therapies stand to reach
I can tell when it wears off because I start getting cravings again
It is better to seek help than to risk making a mistake that could affect the medications efficacy or safety
How Employee Benefits Leaders Can Navigate the GLP-1 Shift By: Stephen Mackie Key Takeaways GLP-1 drugs are effective but complex, with high demand and many potentially eligible employees
The oats provide fiber (helps with constipation, a common GLP-1 side effect), and the chia seeds add omega-3s and more fiber